Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GSK Plans Cervarix NDA Filing Two Years Ahead Of Schedule
Oct 28 2004
•
By
Lee Kalowski
More from Archive
More from Pink Sheet